MEDULLARY CARCINOMA THYROID: A CASE REPORT
ABSTRACT: 18 year female presented with right side solitary thyroid nodule measuring
Articles, journals and conferences in one search. An exact title, DOI or ISSN is listed first.
In the search box: "exact phrase" · -leave out · OR · prefix* · title: author: journal:
ABSTRACT: 18 year female presented with right side solitary thyroid nodule measuring
parathyroid tumors, and pheochromocytoma. MEN 2 is classified into subtypes nbased on clinical features. MEN 2A, which effects 95% of MEN2 families. There are 4 varients 1. Classical MEN2A
ongoing and future clinical studies. Recently, a company sponsored phase 1b/2a study in 36 men was initiated in the U.S. with data expected by year-end. Naturally secreted growth
ongoing and future clinical studies. Recently, a company sponsored phase 1b/2a study in 36 men was initiated in the U.S. with data expected by year-end. Naturally secreted growth
Material and methods: the material consisted of 25 patients (8 women, 17 men) aged 18-62, after 2a, 2b and 3 degree thermal burns, treated at the Rehabilitation Department
cutaneous malignancies while 5(8%) were metastatic cutaneous cancer]. The 5 patients comprised 2 men and 3 women with ages that ranged from 37- 75 years (mean 59.2 years ... scapular region and 1 – wide spread cutaneous…
weeks 0, 2, 6, and every 8 weeks thereafter. In patients receiving interferon α-2a at the time of initiation of infliximab therapy, interferon was ceased before starting infliximab ... evaluated visual acuity, ocular…
Hepatitis C Virus (HCV) is a rapidly evolving pandemic disease that has
virus (HCV) infection among human immunodeficiency virus (HIV) infected men who have sex with men (MSM) has emerged as a public health challenge worldwide. In China, there have been ... Eight HCV NS5B 377-nt partial…
disease process with minimal or no success. With the introduction of interferons (alfa 2a or alfa 2b) with or without additional ribavirin, a modicum of success defined as a reduction ... means of reducing the…
For authors and organisers
Find the right journal for your paper and submit your manuscript.